Search clinical trials for: alprazolam commercial sublingual formulation

Total 22 results

Pfizer's Upjohn has merged with Mylan to form Viatris...

Withdrawn

Bioequivalence of a New and a Commercial Alprazolam Sublingual Formulation

Healthy
Pfizer's Upjohn has merged with Mylan to form Viatris...

Withdrawn

Bioequivalence Of A Test Alprazolam Sublingual Formulation Compared To A Commercial Sublingual Formulation

Healthy
H. Lundbeck A/S

Completed

Bioequivalence Study of Lu AF35700

Healthy

United Kingdom
Pfizer's Upjohn has merged with Mylan to form Viatris...

Withdrawn

Bioequivalence of a New Sublingual and a Reference Alprazolam Immediate Release Tablet Formulation

Healthy
Boehringer Ingelheim

Completed

A Study in Healthy People to Compare 2 Different Formulations of BI 1358894 Tablets Taken With or Without Food

Healthy

Germany
Isfahan University of Medical Sciences

Completed

Alprazolam as Conscious Sedation for Upper Gastrointestinal Endoscopy

Diagnostic Esophagogastroduodenoscopy

Iran, Islamic Republic of
Tibotec Pharmaceuticals, Ireland

Completed

TMC114-TiDP3-C182 - A Study to Compare the Oral Bioavailability of a 800 mg Prototype Tablet Formulation of Darunivar (DRV) to That of the 400 mg Commercial Tablet Formulation in the Presence of Low Dose Ritonavir, Under Fasted and Fed Conditions

HIV Infections
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

Pharmacokinetics Of Alprazolam Sublingual Tablet Versus Conventional Tablet

Anxiety Disorder

United States
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

Bioequivalence of Alprazolam Sublingual vs Oral Tablets

Healthy

India
Genzyme, a Sanofi Company

Completed

A Phase I Study of the Pharmacokinetic Variability and Relative Bioavailability of the Phase 3 and Common Blend Formulations of Eliglustat in Healthy Adult Subjects

Healthy Volunteer

United States
Boehringer Ingelheim

Completed

Pharmacokinetics of Two Different Persantin® Sugar Coated Tablets in Healthy Male Volunteers

Healthy
Boehringer Ingelheim

Terminated

Study to Evaluate Pharmacokinetics of Dipyridamole in Three New Formulations of Asasantin ER in Healthy Female and Male Subjects

Healthy
Boehringer Ingelheim

Completed

Study to Compare the Pharmacokinetics of Dipyridamole in Three Different Asasantin Extended Release (ER) Formulations in Healthy Male and Female Volunteers

Healthy
Isfahan University of Medical Sciences

Completed

Premedication With Alprazolam and Midazolam for Upper Gastrointestinal Endoscopy

Diagnostic Esophagogastroduodenoscopy

Iran, Islamic Republic of
Boehringer Ingelheim

Completed

Bioequivalence of a New Asasantin Formulation Extended Release (ER) Compared to the Commercially Available Asasantin Formulation (Aggrenox®; Extended Release) in Healthy Male and Female Volunteers

Healthy
Boehringer Ingelheim

Completed

Bioavailability of Dipyridamole of Asasantin p.o. in Three Experimental Formulations Relative to the Standard Formulation in Healthy Male Subjects

Healthy
Boehringer Ingelheim

Completed

A Study in Healthy People to Compare Two Different Tablets of BI 685509 and to Test How Food and Esomeprazole Influence the Amount of BI 685509 in the Blood

Healthy

Germany
Takeda

Completed

A Study of Maribavir Pediatric Formulation in Healthy Adult Participants

Healthy Volunteers

United States
Amgen

Completed

Study to Assess the Injection Site Pain Associated With a New Etanercept Formulation in Adults With Rheumatoid Arthritis or Psoriatic Arthritis

Arthritis, Rheumatoid; Arthritis, Psoriatic

United States, Puerto Rico
Alar Pharmaceuticals Inc.

Completed

Single Ascending Dose Study of ALA-1000

Opioid-use Disorder

United States
Halozyme Therapeutics

Completed

CONSISTENT 1: Metabolic and Safety Outcomes of Hylenex Recombinant (Hyaluronidase Human Injection) Preadministered at CSII Infusion Site in Participants With Type 1 Diabetes Mellitus (T1DM)

Type 1 Diabetes Mellitus

United States
Boehringer Ingelheim

Completed

Relative Bioavailability of Telmisartan and HCTZ in Two Experimental Formulations Compared to the Standard Formulation Telmisartan and HCTZ in Healthy Female and Male Subjects

Healthy

3

Subscribe